Reata pharmaceuticals inc stock
Webb1 apr. 2024 · STOCK. The last closing price of the REATA PHARMACEUTICALS INC CLASS A share was $93.98 and has changed by 1.39% since the penultimate trading day. The forecast for the further price development, based on current price information, is -0.61% (time horizon: 1 day) and results in a price target of $93.41. Webbför 2 dagar sedan · View Reata Pharmaceuticals, Inc RETA investment & stock information. Get the latest Reata Pharmaceuticals, Inc RETA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Reata pharmaceuticals inc stock
Did you know?
Webb18 feb. 2024 · Reata Pharmaceuticals Inc. (NASDAQ:RETA) concluded the trading at $48.83 on Friday, February 17 with a rise of 14.38% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $42.69 and 5Y monthly beta was reading 1.25 with its price kept float WebbReata Pharmaceuticals, Inc. (RETA) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed Dow 30 Nasdaq -52.48(-0.43%) Russell 2000 +14.15(+0.80%) Crude Oil +1.73(+2.17%) Reata...
Webbför 16 timmar sedan · Reata Pharma has recently broken out of its tight trading range after gapping into the $80.00 - $96.00 area due to its FDA approval of “Omavoloxone.” With no confirmation of the breakout, investors may still have time to buy into its support or wait for potential confirmation. Symbiotic Inc, S SYM Webb12 apr. 2024 · We remind investors that last month, the FDA approved Reata Pharmaceuticals’ RETA drug Skyclarys, or omaveloxolone, ... Reata Pharmaceuticals, Inc. (RETA) : Free Stock Analysis Report.
Webb4 apr. 2024 · In the last trading session, 1.03 million Reata Pharmaceuticals Inc. (NASDAQ:RETA) shares changed hands as the company’s beta touched 1.36. With the company’s per share price at $93.84 changed hands at $2.92 or 3.21% during last session, the market valuation stood at $3.41B. WebbThe main stock indexes are way down over the past year, but quite a few under-the-radar stocks have bucked the trend. Reata Pharmaceuticals (NASDAQ: RETA) was a clinical-stage biopharmaceutical company until the U.S. Food and Drug Administration (FDA) approved its first treatment on Feb. 28, 2024.
Webb31 mars 2024 · Shares Sold Short 5.03 M Change from Last -39.81% Percent of Float 18.08% Stock Money Flow N/A PROFILE ( RETA) Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company,...
Webb13 apr. 2024 · Shares of RETA stock opened at $96.49 on Thursday. Reata Pharmaceuticals has a 1-year low of $18.47 and a 1-year high of $98.52. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of -11.27 and a beta of 1.52. The stock's fifty day simple moving average is $72.33 and its 200-day simple … p ebt call center numberWebb13 apr. 2024 · A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. p ebt chicagoWebb31 mars 2024 · View the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ. light\u0027s retention scaleWebb13 aug. 2024 · On this news, Reata’s stock price fell $22.13 per share, or 18.12%, to close at $100.00 per share on August 10, 2011. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and... p ebt check balance phone numberWebb27 feb. 2024 · Reata Pharmaceuticals Inc (RETA) stock is down -37.09% while the S&P 500 is up 0.37% as of 12:07 PM on Monday, Feb 27. RETA is down -$16.51 from the previous closing price of $44.51 on volume of 3,746,114 shares. Over the past year the S&P 500 is down -8.90% while RETA is down -14.48%. RETA lost -$8.55 per share the over the last … p ebt contact number californiaWebbAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. p ebt check balance nycWebbFör 1 dag sedan · In the last 3 months, 8 analysts have offered 12-month price targets for Reata Pharmaceuticals. The company has an average price target of $121.38 with a high of $185.00 and a low of $85.00. Below ... p ebt check balance online